Molecular Therapy - Nucleic Acids

Slides:



Advertisements
Similar presentations
Structure and Activity of Strigolactones: New Plant Hormones with a Rich Future Binne Zwanenburg, Tomáš Pospíšil Molecular Plant Volume 6, Issue 1, Pages.
Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Molecular Therapy - Nucleic Acids
Yuming Lu, Jian-Kang Zhu  Molecular Plant 
Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral.
You Can Count on This: Barcoded Hematopoietic Stem Cells
Molecular Therapy - Nucleic Acids
Genome-editing Technologies for Gene and Cell Therapy
Jacek Majewski  The American Journal of Human Genetics 
Volume 8, Issue 12, Pages (December 2015)
162. Stability of Polymer/Plasmid DNA Complexes In Vitro and In Vivo
Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs  Pantazis I. Theotokis, Louise Usher, Christopher.
Molecular Therapy - Nucleic Acids
Volume 27, Issue 3, Pages (March 2015)
Molecular Therapy  Volume 20, Pages S261-S262 (May 2012) DOI: /S (16)
Evolving Gene Therapy in Primary Immunodeficiency
Volume 20, Issue 5, Pages (May 2012)
BARLEX – the Barley Draft Genome Explorer
Spliceosome-Mediated RNA Trans-splicing
Chapter 24 Genomics and DNA Sequencing
Volume 12, Issue 1, Pages (July 2005)
Volume 19, Issue 4, Pages (April 2011)
Volume 26, Issue 2, Pages (February 2018)
Stable Transcriptional Repression and Parasitism of HIV-1
Volume 19, Issue 11, Pages (November 2011)
Molecular Therapy - Nucleic Acids
USH2A Gene Editing Using the CRISPR System
Jan Hoinka, Phuong Dao, Teresa M Przytycka 
Luca Biasco, Michael Rothe, Hildegard Büning, Axel Schambach 
Molecular Therapy - Nucleic Acids
Xiaoyu Chen, Jin Liu, Josephine M. Janssen, Manuel A.F.V. Gonçalves 
IRNA-PseColl: Identifying the Occurrence Sites of Different RNA Modifications by Incorporating Collective Effects of Nucleotides into PseKNC  Pengmian.
Revolutionize Genetic Studies and Crop Improvement with High-Throughput and Genome-Scale CRISPR/Cas9 Gene Editing Technology  Ning Yang, Rongchen Wang,
Genome-editing Technologies for Gene and Cell Therapy
Gang Wang, Na Zhao, Ben Berkhout, Atze T Das  Molecular Therapy 
Volume 148, Issue 3, Pages (March 2015)
In Silico Restriction Enzyme Digests to Minimize Mapping Bias in Genomic Sequencing  Jason Roszik, György Fenyőfalvi, László Halász, Zsolt Karányi, Lóránt.
Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S
CRISPR/Cas9: A Potential Life-Saving Tool. What’s next?
A Sample Extraction Method for Faster, More Sensitive PCR-Based Detection of Pathogens in Blood Culture  John F. Regan, Manohar R. Furtado, Maxim G. Brevnov,
Volume 24, Issue 6, Pages (June 2016)
Molecular Therapy - Methods & Clinical Development
521. Multiplex Genome Editing of TCR°/CD52 Genes as a Platform for “Off the Shelf” Adoptive T-Cell Immunotherapies    Molecular Therapy  Volume 22, Pages.
Molecular Therapy - Methods & Clinical Development
Volume 6, Issue 5, Pages (November 2002)
The Cell Biology of Genomes: Bringing the Double Helix to Life
Volume 8, Issue 6, Pages (December 2003)
iRNA-PseU: Identifying RNA pseudouridine sites
Molecular Therapy  Volume 18, Pages S260-S261 (May 2010) DOI: /S (16)
Molecular Therapy - Nucleic Acids
Computational Genomics of Noncoding RNA Genes
Chapter 4 Genes, Genomes and DNA
In This Issue Molecular Therapy Volume 16, Issue 4, (April 2008)
Molecular Therapy - Nucleic Acids
Molecular Therapy - Nucleic Acids
372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency    Molecular.
Structure prediction: Folding proteins by pattern recognition
Phase 1/2 Open-label Dose-escalation Study of Plasmid DNA Expressing Two Isoforms of Hepatocyte Growth Factor in Patients With Painful Diabetic Peripheral.
Molecular Therapy  Volume 21, Pages S247-S248 (May 2013)
CRISPR/Cas9: Transcending the Reality of Genome Editing
Volume 21, Issue 1, Pages (January 2013)
Thomas J Cradick, Peng Qiu, Ciaran M Lee, Eli J Fine, Gang Bao 
Volume 4, Issue 3, Pages (March 2018)
Volume 20, Issue 6, Pages (June 2012)
Nuclease Target Site Selection for Maximizing On-target Activity and Minimizing Off- target Effects in Genome Editing  Ciaran M Lee, Thomas J Cradick,
Thomas Gaj, Benjamin E Epstein, David V Schaffer  Molecular Therapy 
Making New Connections—Chromosome Conformation Capture for Identification of Disease-Associated Target Genes  Matthew T. Patrick, Lam C. Tsoi, Johann.
Shirley Wong, Roderick A. Slavcev
Volume 12, Issue 6, Pages (December 2007)
Hildegard Büning, Arun Srivastava 
Presentation transcript:

Molecular Therapy - Nucleic Acids GENE-IS: Time-Efficient and Accurate Analysis of Viral Integration Events in Large- Scale Gene Therapy Data  Saira Afzal, Stefan Wilkening, Christof von Kalle, Manfred Schmidt, Raffaele Fronza  Molecular Therapy - Nucleic Acids  Volume 6, Pages 133-139 (March 2017) DOI: 10.1016/j.omtn.2016.12.001 Copyright © 2016 The Authors Terms and Conditions

Figure 1 Comparison of Analysis Time of LAM-PCR Mode of GENE-IS (A) Comparison with VISA, QuickMap, and HISAP for analyzing an in silico dataset of 500 and 5,750 sequences. In both datasets, all reads were informative (with IS). (B) Comparison between different datasets consisting of 5K, 50K, 500K, and 5.0M sequences (K, thousand; M, million). In these datasets, both kind of reads, i.e., informative (with IS) as well as non-informative (without IS) sequences, were present. This was done to depict computational efficiency in original settings, as experimental datasets always contain both types of reads. Molecular Therapy - Nucleic Acids 2017 6, 133-139DOI: (10.1016/j.omtn.2016.12.001) Copyright © 2016 The Authors Terms and Conditions

Figure 2 Histogram of the Analysis Time Consumed by GENE-IS Targeted Sequencing Mode Time required for processing four in silico datasets of 37K, 373K, 3.73M, and 37M reads by GENE-IS is shown. Molecular Therapy - Nucleic Acids 2017 6, 133-139DOI: (10.1016/j.omtn.2016.12.001) Copyright © 2016 The Authors Terms and Conditions

Figure 3 Overview of GENE-IS Framework (A and B) The LAM-PCR (A) and targeted sequencing modes (B). In case of paired-end targeted sequencing, the candidate reads for exact IS are those that contain fusion events of vector and genome in one read and the other read supports the fusion event read. For approximate IS candidate reads, one read of the pair has 100% matching identity with vector and the other with genome region. Molecular Therapy - Nucleic Acids 2017 6, 133-139DOI: (10.1016/j.omtn.2016.12.001) Copyright © 2016 The Authors Terms and Conditions